We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Drug Quality Still Lacking; FDA Considering QbD Incentives
Drug Quality Still Lacking; FDA Considering QbD Incentives
June 8, 2012
BALTIMORE — Despite recurring pharma quality problems, drugmakers are still inclined to meet minimum manufacturing standards set by regulators, rather than make quality central to their business model.